Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs

  • Drug Test Anal. 2016 Sep;8(9):910-9. doi: 10.1002/dta.1889.
Folker Westphal  1 ,  Ulrich Girreser  2 ,  Delia Waldmüller  3
Affiliations
  • 1. State Bureau of Criminal Investigation Schleswig-Holstein, Section Narcotics/Toxicology, Mühlenweg 166, D-24116, Kiel, Germany.
  • 2. Pharmaceutical Institute, Christian-Albrechts-University Kiel, Gutenbergstr. 76, 24118, Kiel, Germany.
  • 3. Center for Education and Science of the Federal Finance Administration, Laboratory Berlin, Grellstr. 18,24, 10409, Berlin, Germany.
PMID: 26606897 DOI: 10.1002/dta.1889
Abstract

In a seizure of German custom authorities four N-(ortho-methoxybenzyl)amines with amphetamine partial structure were obtained as pure compounds: N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine (3,4-DMA-NBOMe (1)), N-(ortho-methoxybenzyl)-4-ethylamphetamine (4-EA-NBOMe (2)), N-(ortho-methoxybenzyl)-4-methylmethamphetamine (4-MMA-NBOMe (3)), and N-(ortho-methoxybenzyl)-5-(2-aminopropyl)benzofuran (5-APB-NBOMe (4)). The compounds have been detected in Germany for the first time and no analytical data had been previously published. Mass spectrometric (MS), infrared (IR) spectroscopic, and nuclear magnetic resonance (NMR) spectroscopic data are presented. Copyright © 2015 John Wiley & Sons, Ltd.

Keywords
3,4-DMA-NBOMe; 4-EA-NBOMe; 4-MMA-NBOMe; 5-APB-NBOMe; GC-MS; IR; NMR; designer drug.
Products